NM_001171.6:c.4015C>T

Variant summary

Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM5PP3_ModeratePP5_Very_Strong

The NM_001171.6(ABCC6):​c.4015C>T​(p.Arg1339Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000478 in 1,611,470 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1339L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

ABCC6
NM_001171.6 missense

Scores

11
3
4

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 0.960

Publications

24 publications found
Variant links:
Genes affected
ABCC6 (HGNC:57): (ATP binding cassette subfamily C member 6) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008]
ABCC6 Gene-Disease associations (from GenCC):
  • arterial calcification, generalized, of infancy, 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • autosomal recessive inherited pseudoxanthoma elasticum
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • arterial calcification of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 14 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 8 uncertain in NM_001171.6
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-16154898-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 265021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.929
PP5
Variant 16-16154899-G-A is Pathogenic according to our data. Variant chr16-16154899-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 6576.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001171.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC6
NM_001171.6
MANE Select
c.4015C>Tp.Arg1339Cys
missense
Exon 28 of 31NP_001162.5
ABCC6
NM_001440309.1
c.3982C>Tp.Arg1328Cys
missense
Exon 28 of 31NP_001427238.1
ABCC6
NM_001440310.1
c.3847C>Tp.Arg1283Cys
missense
Exon 27 of 30NP_001427239.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC6
ENST00000205557.12
TSL:1 MANE Select
c.4015C>Tp.Arg1339Cys
missense
Exon 28 of 31ENSP00000205557.7
ABCC6
ENST00000456970.6
TSL:2
n.*1024C>T
non_coding_transcript_exon
Exon 26 of 29ENSP00000405002.2
ABCC6
ENST00000576204.6
TSL:5
n.878C>T
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152080
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000825
AC:
20
AN:
242560
AF XY:
0.0000912
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000554
Gnomad FIN exome
AF:
0.0000982
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000493
AC:
72
AN:
1459390
Hom.:
0
Cov.:
32
AF XY:
0.0000579
AC XY:
42
AN XY:
725804
show subpopulations
African (AFR)
AF:
0.0000599
AC:
2
AN:
33416
American (AMR)
AF:
0.000203
AC:
9
AN:
44422
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26044
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39560
South Asian (SAS)
AF:
0.000117
AC:
10
AN:
85684
European-Finnish (FIN)
AF:
0.0000565
AC:
3
AN:
53112
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1111074
Other (OTH)
AF:
0.0000995
AC:
6
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152080
Hom.:
0
Cov.:
31
AF XY:
0.0000404
AC XY:
3
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41408
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000537
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000741
AC:
9

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive inherited pseudoxanthoma elasticum Pathogenic:5
Sep 10, 2024
PG23_Medical Genetics Lab, ASST Papa Giovanni XXIII
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jun 15, 2018
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Juno Genomics, Hangzhou Juno Genomics, Inc
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;Novel missense change at an amino acid residue where a different missense change determined to be pathogenic has been seen before.;Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product.;For recessive disorders, detected in trans with a pathogenic variant.;Co-segregation with disease in multiple affected family members in a gene definitively known to cause the disease.

Mar 01, 2021
PXE International
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

Oct 25, 2024
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Pathogenic. Evidence in support of pathogenic classification: Variant is present in gnomAD <0.01 for a recessive condition (v4: 77 heterozygotes, 0 homozygotes); This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic and pathogenic by clinical laboratories in ClinVar and reported in the literature in multiple individuals with pseudoxanthoma elasticum (PMIDs: 32873932, 10954200, 18253096, 15459974, 34906475). Additional information: Variant is predicted to result in a missense amino acid change from arginine to cysteine; This variant is homozygous; This gene is associated with autosomal recessive disease. Older publications suggest dominant disease (OMIM); Multiple alternative amino acid changes at the same position have been observed in gnomAD (v4) (highest allele count: 32 heterozygotes, 0 homozygotes); Loss of function is a known mechanism of disease in this gene and is associated with generalized infantile arterial calcification 2 (MIM#614473) and pseudoxanthoma elasticum (PXE; MIM#264800); Variants in this gene are known to have variable expressivity. Intrafamilial variability with age-dependent severity has been well reported (PMID: 28102862); This variant has been shown to be both maternally and paternally inherited (biallelic) (by trio analysis).

not provided Pathogenic:2
Dec 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1339 of the ABCC6 protein (p.Arg1339Cys). This variant is present in population databases (rs28939702, gnomAD 0.02%). This missense change has been observed in individuals with pseudoxanthoma elasticum (PMID: 10954200, 12384774). ClinVar contains an entry for this variant (Variation ID: 6576). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCC6 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCC6 function (PMID: 24352041, 27994049). This variant disrupts the p.Arg1339 amino acid residue in ABCC6. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16086317, 18157818). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

Sep 07, 2021
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.43
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.94
D
Eigen
Benign
-0.032
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.21
N
LIST_S2
Pathogenic
0.97
D
M_CAP
Uncertain
0.28
D
MetaRNN
Pathogenic
0.93
D
MetaSVM
Pathogenic
0.86
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
0.96
PrimateAI
Uncertain
0.49
T
PROVEAN
Pathogenic
-6.8
D
REVEL
Pathogenic
0.76
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.88
MPC
0.47
ClinPred
0.70
D
GERP RS
-2.5
Varity_R
0.88
gMVP
0.95
Mutation Taster
=14/86
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28939702; hg19: chr16-16248756; COSMIC: COSV104567564; API